SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-005537
Filing Date
2024-01-18
Accepted
2024-01-18 18:56:12
Documents
2
Period of Report
2024-01-16

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3927
2 EX-24 ngne-ex24.htm EX-24 9561
  Complete submission text file 0000950170-24-005537.txt   15203
Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Issuer) CIK: 0001404644 (see all company filings)

IRS No.: 980542593 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Noonberg Sarah B. (Reporting) CIK: 0001706301 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36327 | Film No.: 24543330